journal article·2016-06-01Open access

Solvates, Salts, and Cocrystals: A Proposal for a Feasible Classification System

E. Grothe, H. Meekes, E. Vlieg, J. H. ter Horst, R. de Gelder

Crystal Growth & Design· Volume 16· Issue 6

Abstract

High Resolution Image Download MS PowerPoint Slide The design of pharmaceutical cocrystals has initiated widespread debate on the classification of cocrystals. Current attempts to classify multicomponent crystals suffer from ambiguity, which has led to inconsistent definitions for cocrystals and for multicomponent crystals in general. Inspired by the work of Aitipamula et al. ( Cryst. Growth Des. 2012, 12, 2147–2152), we present a feasible classification system for all multicomponent crystals. The present classification enables us to analyze and classify multicomponent crystal structures present in the Cambridge Structural Database (CSD). This reveals that all seven classes proposed are relevant in terms of frequency of occurrence. Lists of CSD refcodes for all classes are provided. We identified over 5000 cocrystals in the CSD, as well as over 12 000 crystals with more than two components. This illustrates that the possibilities for alternative drug formulations can be increased significantly by considering more than two components in drug design.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Crystallography and molecular interactions · Crystallization and Solubility Studies · Enzyme Structure and Function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands

EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation, Strathclyde Institute of Pharmacy and Biomedical Sciences, Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow G1 1RD, United Kingdom

Funding

Technologiestichting STW

References (24)

Show source-provided references
1. 10.3109/0363904970915049810.3109/03639049709150498 ↗
2. 10.1016/0378-5173(95)04102-810.1016/0378-5173(95)04102-8 ↗
3. 10.1016/j.tips.2012.12.00310.1016/j.tips.2012.12.003 ↗
4. 10.1039/c4ce00316k10.1039/c4ce00316k ↗
5. Generally Recognized as Safe (GRAS);U.S. FDA:College Park, MD, 2011.http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/default.htm(accessed April 4, 2016).
6. Everything Added to Food in the United States (EAFUS);U.S. FDA, 2011.http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm115326.htm(accessed April 4, 2016).
7. Guidance for Industry: Regulatory Classification of Pharmaceutical Co-crystals;U.S. FDA:Silver Spring, MD, 2011.
8. 10.1021/cg300294810.1021/cg3002948 ↗
9. Guidance for Industry: Regulatory Classification of Pharmaceutical Co-crystals;U.S. FDA:Silver Spring, MD, 2013.http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm281764.pdf.
10. 10.1039/b505883j10.1039/b505883j ↗
11. 10.1021/cg900873t10.1021/cg900873t ↗
12. 10.1021/ci00015a00510.1021/ci00015a005 ↗
13. 10.1107/S010876810000050110.1107/S0108768100000501 ↗
14. 10.1021/cg100670k10.1021/cg100670k ↗
15. 10.1039/c1ce06320k10.1039/c1ce06320k ↗
16. 10.1021/ja027845q10.1021/ja027845q ↗
17. 10.1039/b509162d10.1039/b509162d ↗
18. 10.1021/cg901230b10.1021/cg901230b ↗
19. Zulfiya A. · Chin. J. Struct. Chem. · 2010 · 29 · 1185
20. 10.2116/analscix.22.x25110.2116/analscix.22.x251 ↗
21. 10.1107/S010827010900440510.1107/S0108270109004405 ↗
22. 10.1021/cg060327x10.1021/cg060327x ↗
23. 10.1524/ncrs.2010.020210.1524/ncrs.2010.0202 ↗
24. 10.1021/cg400043910.1021/cg4000439 ↗